Max Meyrath, Dr Andy Chevigné and Dr Martyna Szpakowska from the Immuno-Pharmacology and Interactomics research group of the Department of Infection and Immunity (DII) published a book chapter on cancer signalling, in collaboration with international partners. The scientific publication, which was released in February 2020 in Advances in Cancer Research, reviews the roles of atypical chemokine receptors (ACKRs) in the different phases of cancer development, progression and metastasis, their clinical relevance, as well as their implications for cancer therapy.

On Friday, May 29th, the Luxembourg National Research Fund (Fonds National de la Recherche - FNR) announced the results of the second round of financing under its novel COVID-19 Fast Track Call. A total of 21 out of the 55 eligible projects were retained for funding, corresponding to an FNR commitment of EUR 1.12 million. Namely, four LIH projects are among the selected ones, for a total support amounting to over EUR 197,000.

On April 24th, the Research Luxembourg Taskforce officially launched “Predi-COVID” (Luxembourg cohort of positive patients for COVID-19: a stratification study to predict severe prognosis»), a study led by the Department of Population Health (DoPH) of the Luxembourg Institute of Health (LIH).

CON-VINCE, a national research project aiming to evaluate the prevalence and dynamics of the spread of COVID-19 within the Luxembourgish population, was launched at the beginning of April under the umbrella of the Research Luxembourg COVID-19 Task Force.

Prof Rejko Krüger is the Director of Transversal Translational Medicine (TTM) at LIH.

On 8th April, the CON-VINCE study was officially launched, with the aim to assess the spread dynamics of the COVID-19 disease among the Luxembourgish population.

As part of the deconfinement, Luxembourg is calling on its residents and cross-border workers to get tested for COVID-19. It aims to limit the spread of the novel corona virus by voluntary extensive testing until the end of July. This will allow to break infection chains and thus protect family, friends and colleagues. The more tests are carried out, the more new infections can be prevented and the safer everyday life will be.

Prof Claude P. Muller is a medical doctor and chemist by training. As a scientist, he works in the surveillance and management of viral outbreaks at a global level.

Dr Nicole Kiweler, post-doctoral fellow within the Cancer Metabolism Group of the LIH Department of Oncology (DONC), was awarded a EUR 10,000 grant under the LIH Wolfgang Baertz Career Launchpad Award (Legs W. Baertz) programme at the end of March 2020.